Gene expression profiling of the ADRB2 silenced LNCaP cells revealed that UDP-glucuronosyltransferase (UGT) 2B15 and 2B17 were down-regulated; these enzymes control androgen inactivation in prostate cancer [63]. This evidence concerns the gene ADRB2 and Familial prostate cancer.